Home
Cleveland Diagnostics

Cleveland Diagnostics Market Share Analysis for July 2026

Improving cancer decisions - Cleveland Diagnostics offers novel, more accurate testing for early detection of cancer and risk of high-grade disease.

Industry: N/A

Domainclevelanddx.com

Year Founded2013

Employees51 - 200

Annual Revenue$2M - $5M

Cleveland Diagnostics

Cleveland Diagnostics (including company regionals)

clevelanddx.com

See more website traffic and engagement information

Cleveland Diagnostics Revenue up to July 2026 is 2M - 5M

revenue generated by Cleveland Diagnostics top domains

Cleveland Diagnostics top domains revenue over 3 years

Revenue for Cleveland Diagnostics top domains

clevelanddx.com2M - 5M

See more with Sales Intelligence

Total visits to Cleveland Diagnostics's top domains

Understand Cleveland Diagnostics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

clevelanddx.com2.8K

See more with Sales Intelligence

Avg. visit duration in Cleveland Diagnostics's top domains

Analyze Cleveland Diagnostics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

clevelanddx.com00:01:01

See more with Sales Intelligence

Avg. pageviews on Cleveland Diagnostics's top domains

See how Cleveland Diagnostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

clevelanddx.com2.00

See more with Sales Intelligence

Cleveland Diagnostics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Cleveland Diagnostics

These are the website technologies, by industry, used by Cleveland Diagnostics top domains

Advertising (4)

DoubleClick

Content Management System (3)

Wix

Conversion & Analytics (3)

Google Analytics

Marketing (3)

Google Marketing Platform

More Technologies

13

See all

News & Signals from Cleveland Diagnostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCleveland Diagnostics, Inc. hired Rich Ramko as Board of Directors on Jun 9th '26.Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, has appointed Rich Ramko to its Board of Directors.

NewsCleveland Diagnostics, Inc. launched IsoPSA Test for Prostate Cancer on Mar 1st '26.* Cleveland Diagnostics who recently announced their new IsoPSA Test for Prostate Cancer received FDA Approval and can now be used in labs nationwide.

NewsCleveland Diagnostics, Inc. hires Michael Iskra as chief executive officer (CEO.Cleveland Diagnostics has appointed Michael Iskra as chief executive officer (CEO) to lead the company's commercial expansion following US Food and Drug Administration (FDA) approval of its IsoPSA in vitro diagnostic kit.